These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 29543771
1. Synthesis of New C- and N-β-d-Glucopyranosyl Derivatives of Imidazole, 1,2,3-Triazole and Tetrazole, and Their Evaluation as Inhibitors of Glycogen Phosphorylase. Kun S, Bokor É, Sipos Á, Docsa T, Somsák L. Molecules; 2018 Mar 15; 23(3):. PubMed ID: 29543771 [Abstract] [Full Text] [Related]
3. Synthesis of 1-(D-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors. Bokor E, Docsa T, Gergely P, Somsák L. Bioorg Med Chem; 2010 Feb 15; 18(3):1171-80. PubMed ID: 20080412 [Abstract] [Full Text] [Related]
4. New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase. Kun S, Bokor É, Varga G, Szőcs B, Páhi A, Czifrák K, Tóth M, Juhász L, Docsa T, Gergely P, Somsák L. Eur J Med Chem; 2014 Apr 09; 76():567-79. PubMed ID: 24608000 [Abstract] [Full Text] [Related]
5. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors. Kun S, Begum J, Kyriakis E, Stamati ECV, Barkas TA, Szennyes E, Bokor É, Szabó KE, Stravodimos GA, Sipos Á, Docsa T, Gergely P, Moffatt C, Patraskaki MS, Kokolaki MC, Gkerdi A, Skamnaki VT, Leonidas DD, Somsák L, Hayes JM. Eur J Med Chem; 2018 Mar 10; 147():266-278. PubMed ID: 29453094 [Abstract] [Full Text] [Related]
6. Synthesis of 2-(β-D-glucopyranosyl)-5-(substituted-amino)-1,3,4-oxa- and -thiadiazoles for the inhibition of glycogen phosphorylase. Szőcs B, Tóth M, Docsa T, Gergely P, Somsák L. Carbohydr Res; 2013 Nov 15; 381():187-95. PubMed ID: 23582340 [Abstract] [Full Text] [Related]
7. Synthesis of C-β-d-glucopyranosyl derivatives of some fused azoles for the inhibition of glycogen phosphorylase. Szennyes E, Bokor É, Docsa T, Sipos Á, Somsák L. Carbohydr Res; 2019 Jan 15; 472():33-41. PubMed ID: 30453096 [Abstract] [Full Text] [Related]
8. Synthesis of substituted 2-(β-D-glucopyranosyl)-benzimidazoles and their evaluation as inhibitors of glycogen phosphorylase. Bokor É, Szilágyi E, Docsa T, Gergely P, Somsák L. Carbohydr Res; 2013 Nov 15; 381():179-86. PubMed ID: 23419607 [Abstract] [Full Text] [Related]
13. Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase. Tóth M, Kun S, Bokor E, Benltifa M, Tallec G, Vidal S, Docsa T, Gergely P, Somsák L, Praly JP. Bioorg Med Chem; 2009 Jul 01; 17(13):4773-85. PubMed ID: 19450985 [Abstract] [Full Text] [Related]
14. Synthesis, enzyme kinetics and computational evaluation of N-(β-D-glucopyranosyl) oxadiazolecarboxamides as glycogen phosphorylase inhibitors. Polyák M, Varga G, Szilágyi B, Juhász L, Docsa T, Gergely P, Begum J, Hayes JM, Somsák L. Bioorg Med Chem; 2013 Sep 15; 21(18):5738-47. PubMed ID: 23938052 [Abstract] [Full Text] [Related]
16. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase. Kantsadi AL, Bokor É, Kun S, Stravodimos GA, Chatzileontiadou DSM, Leonidas DD, Juhász-Tóth É, Szakács A, Batta G, Docsa T, Gergely P, Somsák L. Eur J Med Chem; 2016 Nov 10; 123():737-745. PubMed ID: 27522507 [Abstract] [Full Text] [Related]
17. Efficient atropodiastereoselective access to 5,5'-bis-1,2,3-triazoles: studies on 1-glucosylated 5-halogeno 1,2,3-triazoles and their 5-substituted derivatives as glycogen phosphorylase inhibitors. Goyard D, Chajistamatiou AS, Sotiropoulou AI, Chrysina ED, Praly JP, Vidal S. Chemistry; 2014 Apr 25; 20(18):5423-32. PubMed ID: 24677199 [Abstract] [Full Text] [Related]
18. Probing the β-pocket of the active site of human liver glycogen phosphorylase with 3-(C-β-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors. Kyriakis E, Solovou TGA, Kun S, Czifrák K, Szőcs B, Juhász L, Bokor É, Stravodimos GA, Kantsadi AL, Chatzileontiadou DSM, Skamnaki VT, Somsák L, Leonidas DD. Bioorg Chem; 2018 Apr 25; 77():485-493. PubMed ID: 29454281 [Abstract] [Full Text] [Related]
19. Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors. Homolya L, Mathomes RT, Varga L, Docsa T, Juhász L, Hayes JM, Somsák L. Int J Mol Sci; 2024 Apr 23; 25(9):. PubMed ID: 38731811 [Abstract] [Full Text] [Related]
20. Synthesis of 4-amidomethyl-1-glucosyl-1,2,3-triazoles and evaluation as glycogen phosphorylase inhibitors. Goyard D, Docsa T, Gergely P, Praly JP, Vidal S. Carbohydr Res; 2015 Jan 30; 402():245-51. PubMed ID: 25498027 [Abstract] [Full Text] [Related] Page: [Next] [New Search]